Cargando…
Improving Outcomes in HER2-Positive Breast Cancer: Analysis and Application of Evolving Data and Best Practices
Through expert, case-based discussion, Jame Abraham, MD, and Kelley Mayden, MSN, FNP, AOCNP®, presented existing and emerging data for current and investigational therapies for HER2-positive breast cancer and their associated adverse events, in addition to best practices for managing central nervous...
Autores principales: | Abraham, Jame, Mayden, Kelley D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857326/ https://www.ncbi.nlm.nih.gov/pubmed/33598324 http://dx.doi.org/10.6004/jadpro.2020.11.3.11 |
Ejemplares similares
-
Hormone Receptor–Positive, HER2-Negative Breast Cancer: Recent Advances and Best Practices
por: Schwartzberg, Lee, et al.
Publicado: (2020) -
Evidence-Based Oncology Practice: Competencies for Improved Patient Outcomes
por: Mayden, Kelley D.
Publicado: (2019) -
Integrating Best Practices to Improve Outcomes in Relapsed/Refractory Multiple Myeloma
por: Pierre, Amy E., et al.
Publicado: (2020) -
Advancing the Care of Women With HER2-Positive Metastatic Breast Cancer
por: Beasley, Marcie, et al.
Publicado: (2023) -
Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study
por: Di Maio, Massimo, et al.
Publicado: (2023)